doorgaan naar inhoud
Prescription drugs Voorbeeldweergave van dit item
SluitenVoorbeeldweergave van dit item
Bezig met controle...

Prescription drugs

Auteur: Sylvia Engdahl
Uitgever: Detroit : Greenhaven Press/Gale Cengage Learning, ©2008.
Serie: Current controversies.
Editie/Formaat:   Boek : EngelsAlle edities en materiaalsoorten bekijken.
Database:WorldCat
Beoordeling:

(nog niet beoordeeld) 0 met beoordelingen - U bent de eerste

Onderwerpen
Meer in deze trant

 

Zoeken naar een in de bibliotheek beschikbaar exemplaar

&AllPage.SpinnerRetrieving; Bibliotheken met dit item worden gezocht…

Details

Aanvullende fysieke materiaalsoort: Online version:
Prescription drugs.
Detroit : Greenhaven Press/Gale Cengage Learning, c2008
(OCoLC)768252756
Genre: Internetbron
Soort document: Boek, Internetbron
Alle auteurs / medewerkers: Sylvia Engdahl
ISBN: 9780737739626 0737739622 9780737739633 0737739630
OCLC-nummer: 192079717
Beschrijving: 246 p. ; 24 cm.
Inhoud: Is too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects / Hazel Muir --
Some prescription drugs on the market are unsafe / Consumer reports --
Prescription drugs can cause serious harm when risks are ignored / Susan Kelleher --
Post-marketing study of prescription drugs is not adequate / David J. Graham --
No : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents / Scott Gottlieb --
Panic over prescription-drug risks leads people to stop taking needed medication / Irene S. Levine --
Safety concerns about prescription drugs are exaggerated and will result in higher prices / Henry I. Miller --
Lengthy approval process for prescription drugs costs lives / Gilbert L. Ross --
Terminally ill patients should be allowed to use experimental drugs / Sigrid Fry-Revere --
Do pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview / Carol Rados --
Yes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases / Ray Moynihan, Alan Cassels --
Drug promotion plays on people's fears of future illness / Barbara Mintzes --
Drug promotion has led to the overmedication of children / Anne Taylor Fleming --
No : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people / Glenn Harlan Reynolds --
Improved prescription drugs mean better medical treatment and less illness / Alan F. Holmer --
Direct-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases / Paul Antony. Do prescription drugs in America cost too much? Rising cost of prescription drugs : an overview --
Yes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry / Katharine Greider --
Importing less-costly prescription drugs from abroad should be allowed / Nelda Barnett --
New cancer drugs cost more than their brief extending of life may be worth / Daniel Costello --
No : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones / Peter W. Huber --
Medical innovation would stop if the government controlled drug prices / Sidney Taurel --
Controlling drug prices would reduce access to medicine / Doug Bandow --
Are dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors / Adriane Fugh-Berman, Shahram Ahari --
Media reporting about prescription drugs is often inaccurate / Richard A. Deyo, Donald L. Patrick --
Prescription drugs are often abused / Nichole Aksamit --
Young people often trade prescription drugs with friends / Amy Harmon --
Teens use prescription drugs to get high / Donna Leinwand.
Serietitel: Current controversies.
Verantwoordelijkheid: Sylvia Engdahl, book editor.
Meer informatie:

Beoordelingen

Beoordelingen door gebruikers
Beoordelingen van GoodReads worden opgehaald...
Bezig met opvragen DOGObooks-reviews...

Tags

U bent de eerste.

Vergelijkbare items

Verwante onderwerpen:(3)

Gebruiker-lijsten met dit item (2)

Bevestig deze aanvraag

Misschien heeft u dit item reeds aangevraagd. Selecteer a.u.b. Ok als u toch wilt doorgaan met deze aanvraag.

Gekoppelde data


<http://www.worldcat.org/oclc/192079717>
library:oclcnum"192079717"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/192079717>
rdf:typeschema:Book
schema:about
<http://id.worldcat.org/fast/1060129>
rdf:typeschema:Intangible
schema:name"Pharmaceutical industry"@en
schema:name"Pharmaceutical industry."@en
schema:about
<http://id.worldcat.org/fast/1060194>
rdf:typeschema:Intangible
schema:name"Pharmaceutical policy"@en
schema:name"Pharmaceutical policy."@en
schema:about
schema:about
schema:about
schema:about
<http://id.worldcat.org/fast/898888>
rdf:typeschema:Intangible
schema:name"Drugs--Public opinion"@en
schema:name"Drugs--Public opinion."@en
schema:about
schema:about
schema:contributor
schema:copyrightYear"2008"
schema:datePublished"2008"
schema:exampleOfWork<http://worldcat.org/entity/work/id/119960281>
schema:inLanguage"en"
schema:name"Prescription drugs"@en
schema:numberOfPages"246"
schema:publisher
schema:url
schema:workExample
schema:workExample

Content-negotiable representations

Venster sluiten

Meld u aan bij WorldCat 

Heeft u geen account? U kunt eenvoudig een nieuwe gratis account aanmaken.